Double-Blind, Placebo-Controlled, Randomized Phase I/IIa Study (Safety and Efficacy) with Buspirone/Levodopa/Carbidopa (SpinalonTM) in Subjects with Complete AIS A or Motor-Complete AIS B Spinal Cord Injury - Concepedia

Concepedia

Publication | Closed Access

Double-Blind, Placebo-Controlled, Randomized Phase I/IIa Study (Safety and Efficacy) with Buspirone/Levodopa/Carbidopa (SpinalonTM) in Subjects with Complete AIS A or Motor-Complete AIS B Spinal Cord Injury

29

Citations

0

References

2017

Year

Mohan Radhakrishna, Inge Steuer, François Prince, Mary B. Roberts, David Mongeon, Maryam Kia, Sasha Dyck Holzinger, Gilbert Matte, Mario Vaillancourt, Pierre A. Guertin

Current Pharmaceutical Design

Abstract

Therefore, this study provides evidence of safety and preliminary efficacy following a single administration of SpinalonTM in subjects with SCI.